908 Devices Inc.
General ticker "MASS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $259.1M (TTM average)
908 Devices Inc. follows the US Stock Market performance with the rate: 55.6%.
Estimated limits based on current volatility of 2.9%: low 11.38$, high 12.05$
Factors to consider:
- Total employees count: 172 (-30.1%) as of 2025
- US accounted for 73.4% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: History of losses, Dependence on large orders, Market volatility, Innovation failure, Market competition
- Current price 43.6% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.33$, 7.84$]
- 2026-12-31 to 2027-12-31 estimated range: [3.30$, 7.70$]
Financial Metrics affecting the MASS estimates:
- Positive: with PPE of -7.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: 0.47 < Industry inventory ratio change (median), % of 0.70
Short-term MASS quotes
Long-term MASS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $50.23MM | $59.63MM | $56.20MM |
| Operating Expenses | $92.99MM | $136.35MM | $80.38MM |
| Operating Income | $-42.76MM | $-76.72MM | $-24.18MM |
| Non-Operating Income | $6.15MM | $4.23MM | $-9.16MM |
| Interest Expense | $0.20MM | $0.00MM | $0.00MM |
| R&D Expense | $21.90MM | $25.50MM | $13.80MM |
| Income(Loss) | $-36.61MM | $-72.49MM | $-33.34MM |
| Taxes | $-0.21MM | $-0.28MM | $-0.07MM |
| Net Income(Loss)* | $-36.40MM | $-72.21MM | $-36.64MM |
| Stockholders Equity | $165.49MM | $114.59MM | $143.70MM |
| Inventory | $14.94MM | $16.17MM | $12.99MM |
| Assets | $202.98MM | $159.48MM | $190.07MM |
| Operating Cash Flow | $-25.06MM | $-30.25MM | $-23.69MM |
| Capital expenditure | $2.04MM | $0.60MM | $0.95MM |
| Investing Cash Flow | $-26.40MM | $-46.32MM | $50.75MM |
| Financing Cash Flow | $-15.94MM | $-0.38MM | $-0.70MM |
| Earnings Per Share** | $-1.13 | $-2.12 | $-1.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.